Michael Burry's REGN Position Overview
Michael Burry (via Scion Asset Management, LLC) currently holds 15,000 shares of Regeneron Pharmaceuticals, Inc. (REGN) worth $0, representing 0.00% of the portfolio. First purchased in 2025-Q2, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Michael Burry has initiated a new position in REGN, representing a fresh investment thesis on this company.
Analysis based on 13F filings available since 2013 Q2
Michael Burry's Regeneron Pharmaceuticals (REGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Regeneron Pharmaceuticals (REGN) Trades by Michael Burry
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2025 | +15,000 | New Buy | 15,000 | $525.00 |
| Q3 2025 | -15,000 | Sold Out | 15,000 | $0.00 |
Michael Burry's Regeneron Pharmaceuticals Investment FAQs
Michael Burry first purchased Regeneron Pharmaceuticals, Inc. (REGN) in Q2 2025, acquiring 15,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Michael Burry has held Regeneron Pharmaceuticals, Inc. (REGN) for 2 quarters since Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Michael Burry's largest addition to Regeneron Pharmaceuticals, Inc. (REGN) was in Q2 2025, adding 15,000 shares worth $7.88 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Michael Burry's firm, Scion Asset Management, LLC, owns 15,000 shares of Regeneron Pharmaceuticals, Inc. (REGN), valued at approximately $0. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Regeneron Pharmaceuticals, Inc. (REGN) represents approximately 0.00% of Michael Burry's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Michael Burry's peak holding in Regeneron Pharmaceuticals, Inc. (REGN) was 15,000 shares, as reported at the end of Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.